ASCO 2016 – Lung Cancer


Benjamin P. Levy, MD, provides an overview of evolving strategies to manage patients with acquired TKI resistance in advanced non–small-cell lung cancer with a focus on identifying and treating t790m. Read More ›

Page 3 of 3